Lineage Cell Therapeutics (LCTX) Capital Leases (2015 - 2026)
Lineage Cell Therapeutics' (LCTX) quarterly Capital Leases came in at $22000.0 in Q1 2026, down 56.86% year-on-year from $51000.0 in Q1 2025, and down 31.25% quarter-over-quarter from $32000.0 in Q4 2025.
Lineage Cell Therapeutics (LCTX) Capital Leases (2015 - 2026) Analysis & Trends
Lineage Cell Therapeutics' Capital Leases history runs 12 years deep, the most recent figure standing at $22000.0 for Q1 2026.
- On a quarterly basis, Capital Leases fell 56.86% year-over-year to $22000.0 in Q1 2026; TTM through Mar 2026 was $22000.0, a 56.86% decrease from a year earlier, with the FY2025 full-year figure at $32000.0, down 52.24% from the prior year.
- Capital Leases slipped to $22000.0 in Q1 2026 per LCTX's latest filing, from $32000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $133000.0 in Q1 2023 and bottomed at $16000.0 in Q3 2022.
- The 5-year median for Capital Leases is $67000.0 (2024), against an average of $62705.9.
- Across the five-year window, Capital Leases soared 506.25% in 2023 and tumbled 56.86% in 2026, its largest moves.
- Year by year, Capital Leases stood at $84000.0 in 2022, then grew by 8.33% to $91000.0 in 2023, then decreased by 26.37% to $67000.0 in 2024, then slumped by 52.24% to $32000.0 in 2025, then tumbled by 31.25% to $22000.0 in 2026.
- Per Business Quant, the three latest LCTX Capital Leases figures stand at $22000.0 (Q1 2026), $32000.0 (Q4 2025), and $40000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Lineage Cell Therapeutics | 251.15 Mn | 188.44 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 68,000.00 |
| Mar 31, 2024 | 79,000.00 |
| Dec 31, 2023 | 91,000.00 |
| Sep 30, 2023 | 97,000.00 |
| Jun 30, 2023 | 113,000.00 |
| Mar 31, 2023 | 133,000.00 |
| Dec 31, 2022 | 84,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 16,000.00 |